ARV-806

· Arvinas Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARV-806, covering 2026-02-19 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation [Phase 1, Phase 2]